These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25279290)

  • 21. Evaluation of Peak Inspiratory Flow Rate in Hospitalized Palliative Care Patients with COPD.
    Borris J; Cook H; Chae S; Walker KA; McPherson ML
    Pharmacy (Basel); 2023 Jul; 11(4):. PubMed ID: 37489344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spirometry Measurement of Peak Inspiratory Flow Identifies Suboptimal Use of Dry Powder Inhalers in Ambulatory Patients with COPD.
    Duarte AG; Tung L; Zhang W; Hsu ES; Kuo YF; Sharma G
    Chronic Obstr Pulm Dis; 2019 Jul; 6(3):246-255. PubMed ID: 31189057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between Hand Grip Strength and Peak Inspiratory Flow Rate in Patients with Stable Chronic Obstructive Pulmonary Disease.
    Suriyakul A; Saiphoklang N; Barjaktarevic I; Cooper CB
    Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peak Inspiratory Flow Rate in Chronic Obstructive Pulmonary Disease: Implications for Dry Powder Inhalers.
    Ghosh S; Ohar JA; Drummond MB
    J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):381-387. PubMed ID: 28933581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of Appropriate Inhalation Technique for Mometasone Furoate Dry Powder Inhaler.
    Yokoyama H; Ito K; Mihashi H; Shiraishi Y; Takayanagi R; Yamada Y
    Biol Pharm Bull; 2016; 39(10):1576-1580. PubMed ID: 27725433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of Low Peak Inspiratory Flow Rate at Discharge in Patients Hospitalized for COPD Exacerbation.
    Sharma G; Mahler DA; Mayorga VM; Deering KL; Harshaw O; Ganapathy V
    Chronic Obstr Pulm Dis; 2017 Jul; 4(3):217-224. PubMed ID: 28848933
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy and Safety of Salmeterol/Fluticasone Propionate Combination Delivered by the Diskustrade mark or Pressurised Metered-Dose Inhaler in Children with Asthma.
    Bracamonte T; Schauer U; Emeryk A; Godwood A; Balsara S
    Clin Drug Investig; 2005; 25(1):1-11. PubMed ID: 17523742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence of adequacy of the performance of the Pulvinal by measuring through-device peak inspiratory flow rate in severe airways obstruction in adults and children.
    Negro RD; Micheletto C; Tognella S; Clayton N; Cantini L; Woodcock A
    J Aerosol Med; 2001; 14(3):343-9. PubMed ID: 11693846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and COPD phenotype for a suboptimal peak inspiratory flow rate against the simulated resistance of the Diskus® dry powder inhaler.
    Mahler DA; Waterman LA; Gifford AH
    J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):174-9. PubMed ID: 23025451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate.
    Mahler DA; Waterman LA; Ward J; Gifford AH
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):103-9. PubMed ID: 23745526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aerosol drug-delivery and short-term clinical outcomes of suboptimal peak inspiratory flow rate in chronic obstructive pulmonary disease.
    Harb HS; Ibrahim Laz N; Rabea H; Madney YM; Boshra MS; Abdelrahim MEA
    Int J Clin Pract; 2021 Dec; 75(12):e14845. PubMed ID: 34519141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of device resistance and inhalation flow rate on the lung deposition of orally inhaled mannitol dry powder.
    Yang MY; Verschuer J; Shi Y; Song Y; Katsifis A; Eberl S; Wong K; Brannan JD; Cai W; Finlay WH; Chan HK
    Int J Pharm; 2016 Nov; 513(1-2):294-301. PubMed ID: 27639621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exhalation immediately before inhalation optimizes dry powder inhaler use.
    Kondo T; Hibino M; Tanigaki T; Ohe M; Kato S
    J Asthma; 2015; 52(9):935-9. PubMed ID: 26513654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD.
    Svedsater H; Dale P; Garrill K; Walker R; Woepse MW
    BMC Pulm Med; 2013 Dec; 13():72. PubMed ID: 24314123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ciprofloxacin Dry Powder for Inhalation: Inspiratory Flow in Patients with Non-cystic Fibrosis Bronchiectasis.
    Stass H; Nagelschmitz J; Kappeler D; Sommerer K; Patzlaff A; Weimann B
    J Aerosol Med Pulm Drug Deliv; 2019 Jun; 32(3):156-163. PubMed ID: 30848695
    [No Abstract]   [Full Text] [Related]  

  • 36. [Peak inspiratory flow generated through different analogue dry powder inhalers in Shenzhen healthy preschool children].
    Zhang QL; Zheng JP; Pan WH; He H; Chen GL; An JY; Yuan LF; Luo DF
    Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):98-103. PubMed ID: 19099680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peak-Inspiratory-Flow-Rate Guided Inhalation Therapy Reduce Severe Exacerbation of COPD.
    Chen SY; Huang CK; Peng HC; Tsai HC; Huang SY; Yu CJ; Chien JY
    Front Pharmacol; 2021; 12():704316. PubMed ID: 34267665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in inhaler inhalation acoustic features during induced bronchoconstriction: a pilot study.
    McCartan TA; Taylor TE; Sulaiman I; Costello RW; Reilly RB
    Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():3749-3752. PubMed ID: 28269105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influences of gender and anthropometric features on inspiratory inhaler acoustics and peak inspiratory flow rate.
    Taylor TE; Holmes MS; Sulaiman I; Costello RW; Reilly RB
    Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():2227-30. PubMed ID: 26736734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of salbutamol via Easyhaler unaffected by low inspiratory flow.
    Koskela T; Malmström K; Sairanen U; Peltola S; Keski-Karhu J; Silvasti M
    Respir Med; 2000 Dec; 94(12):1229-33. PubMed ID: 11192960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.